Results 61 to 70 of about 4,991 (157)

First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran

Journal of Infection in Developing Countries, 2013
Mucocutaneous leishmaniasis, which mostly occurs in the New World, is mainly associated with Leishmania braziliensis and to a lesser degree L. panamensis and L. amazonensis infections.
Abdolvahab Alborzi, Gholam R Pouladfar, Abdolkarim Ghadimi Moghadam, Armin Attar, Nima Drakhshan, Mohsen Khosravi Maharlooei, Mohsen Kalantari   +6 more
doaj   +1 more source

Atypical Manifestations of Old World Cutaneous Leishmaniasis: A Systematic Review and Clinical Atlas of Unusual Clinical and Specific Anatomical Presentations

Health Science Reports, Volume 8, Issue 9, September 2025.
ABSTRACT Background and Aims Cutaneous leishmaniasis (CL) represents the most common form of leishmaniasis. It imposes a significant medical burden due to long‐lasting ulcers and disfiguring scars, underscoring the need for comprehensive CL control strategies, particularly in endemic regions.
Bahareh Abtahi‐Naeini, Seyed Naser Emadi, Zabihollah Shahmoradi, Mahsa Pourmahdi‐Boroujeni, Ali Saffaei, Fereshte Rastegarnasab   +5 more
wiley   +1 more source

Leishmaniases of the New World from a historical and global perspective, from the 1930s to the 1960s [PDF]

História, Ciências, Saúde: Manguinhos
The first autochthonous cases of cutaneous and mucocutaneous leishmaniasis in the Americas were described in 1909, but visceral leishmaniasis only erupted as a public health problem in the region in 1934.
Jaime Larry Benchimol
doaj   +3 more sources

Mucocutaneous Leishmaniasis Causing Airway Compromise

Annals of Internal Medicine: Clinical Cases
A 37-year-old man presented with dyspnea and erythematous, nodular facial lesions. An examination revealed nasopharyngeal edema, and imaging showed prevertebral swelling. An extensive infectious and autoimmune evaluation was negative.
Soziema Salia, Maria E. Mesalles Ramirez, Rabin K. Shrestha   +2 more
doaj   +1 more source

The accuracy of the Montenegro skin test for leishmaniasis in PCR-negative patients

Revista da Sociedade Brasileira de Medicina Tropical, 2020
INTRODUCTION: As highly specific molecular biology-based techniques may not be sensitive enough for the diagnosis of American tegumentary leishmaniasis (ATL), clinicians frequently rely on immunological tests before treatment initiation.
Ana Bárbara Sapienza Pinheiro, Patricia Shu Kurizky, Marina de Freitas Ferreira, Marco Antonio de Souza Mota, Jaqueline Santos Ribeiro, Edson Zuza de Oliveira Filho, Carlos Augusto Souza, Daniel Holanda Barroso, Raimunda Nonata Ribeiro Sampaio, Ciro Martins Gomes   +9 more
doaj   +1 more source

Antiprotozoal Activity of Highly Substituted Pyrazole and Pyrimidine Derivatives

ChemMedChem, Volume 20, Issue 16, August 16, 2025.
Based on previously identified antimalarial agents, a series of highly substituted pyrazole and pyrimidines derivatives has been synthesized and tested for antiplasmodial and antileishmanial activity. Selected derivatives show promising antiplasmodial effect with a predicted favorable pharmacokinetic profile.
Matteo Lusardi, Nicoletta Basilico, Erika Iervasi, Chiara Brullo, Silvia Parapini, Marco Ponassi, Camillo Rosano, Andrea Spallarossa   +7 more
wiley   +1 more source

Cerebral Complication of Cutaneous Leishmaniasis: about a case

Journal de la Faculté de Médecine d'Oran, 2022
Leishmaniasis (L) is a cutaneous, mucocutaneous, or visceral disease caused by intracellular Leishmania protozoan parasites that are transmitted by the bite of female sand flies.
Schahrazed Linda MAGUENOUCHE, Radia BENALIA, Samira Makri MOKRANE   +2 more
doaj  

Interventions for American cutaneous and mucocutaneous leishmaniasis

Cochrane Database of Systematic Reviews, 2009
Pentavalent antimonial drugs are the most prescribed treatment for American cutaneous and mucocutaneous leishmaniasis. Other drugs have been used with varying success.To assess the effects of therapeutic interventions for American cutaneous and mucocutaneous leishmaniasis.We searched the Cochrane Skin Group Specialised Register (January 2009), the ...
Urbà, González, Mariona, Pinart, Mónica, Rengifo-Pardo, Antonio, Macaya, Jorge, Alvar, John A, Tweed   +5 more
openaire   +5 more sources

Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report

Memorias do Instituto Oswaldo Cruz, 2004
Severe mucocutaneous (MCL) and diffuse (DCL) forms of American cutaneous leishmaniasis (ACL) are infrequent in Venezuela. Chemotherapy produces only transitory remission in DCL, and occasional treatment failures are observed in MCL.
Jacinto Convit, Marian Ulrich, María Argelia Polegre, Angela Avila, Noris Rodríguez, Maria Ilina Mazzedo, Belkis Blanco   +6 more
doaj   +1 more source

Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review

Dermatology Research and Practice, 2018
The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalent antimonials, sodium stibogluconate, or meglumine antimoniate.
Taisa Rocha Navasconi Berbert, Tatiane França Perles de Mello, Priscila Wolf Nassif, Camila Alves Mota, Aline Verzignassi Silveira, Giovana Chiqueto Duarte, Izabel Galhardo Demarchi, Sandra Mara Alessi Aristides, Maria Valdrinez Campana Lonardoni, Jorge Juarez Vieira Teixeira, Thaís Gomes Verziganassi Silveira   +10 more
doaj   +1 more source